pioglitazone has been researched along with Experimental Mammary Neoplasms in 2 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Excerpt | Relevance | Reference |
---|---|---|
"Pioglitazone was administered in the diet at two concentrations (10 ppm and 100 ppm), the chemoprevention was initiated 12 days before carcinogenesis induction and lasted until the termination of the experiment." | 1.37 | Metabolic effects of pioglitazone in chemically-induced mammary carcinogenesis in rats. ( Ahlers, I; Ahlersová, E; Bojková, B; Garajová, M; Kajo, K; Kassayová, M; Kisková, T; Kubatka, P; Mokáň, M; Orendáš, P; Péč, M, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bojková, B | 2 |
Orendáš, P | 2 |
Kajo, K | 2 |
Kubatka, P | 2 |
Výbohová, D | 1 |
Bálentová, S | 1 |
Kružliak, P | 1 |
Zulli, A | 1 |
Demečková, V | 1 |
Péč, M | 2 |
Adamkov, M | 1 |
Garajová, M | 1 |
Mokáň, M | 1 |
Kassayová, M | 1 |
Kisková, T | 1 |
Ahlersová, E | 1 |
Ahlers, I | 1 |
2 other studies available for pioglitazone and Experimental Mammary Neoplasms
Article | Year |
---|---|
Role of high-fat diet on the effect of pioglitazone and melatonin in a rat model of breast cancer.
Topics: Animals; Antioxidants; Carcinogens; Diet, High-Fat; Disease Models, Animal; Drug Therapy, Combinatio | 2016 |
Metabolic effects of pioglitazone in chemically-induced mammary carcinogenesis in rats.
Topics: Animals; Corticosterone; Female; Glycogen; Heart; Hyperglycemia; Hyperinsulinism; Lipid Peroxidation | 2011 |